FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula 
representing (2S)-3-(4-cyano-3-fluorphenoxy)-N-(4-cyano-3-methylpheniyl)-2-hydroxy-2-methylpropionamide which exhibits action modulating androgen receptor activity.
EFFECT: production of a pharmaceutical composition and a method of treating or preventing the conditions caused by androgen receptors.
3 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SELECTIVE ANDROGEN RECEPTOR DESTROYING (SARD) LIGANDS AND METHODS OF USING THEM | 2016 |
|
RU2689988C2 |
| FLUORINE-CONTAINING TEVINOL AND ORVINOL DERIVATIVES AND METHODS OF THEIR OBTAINING (VERSIONS) | 2012 |
|
RU2506265C1 |
| BENZO[d] ISOXAZOLE-3 DAAO INHIBITORS | 2004 |
|
RU2384574C2 |
| METHOD OF TREATING ANDROGEN RECEPTOR (AR)-POSITIVE FORMS OF BREAST CANCER USING SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARM) | 2013 |
|
RU2717835C2 |
| SIGMA-RECEPTOR INHIBITORS | 2005 |
|
RU2417987C2 |
| NUCLEAR RECEPTOR BINDING AGENTS | 2011 |
|
RU2604666C2 |
| ANDROGEN RECEPTOR SELECTIVE DESTROYING (SARD) LIGANDS AND METHODS OF THEIR USE | 2017 |
|
RU2795431C2 |
| METHOD OF OBTAINING DERIVATIVES OF 7-(HETERO)ARYL-4,5,6,7-TETRAHYDRO[1,2,3]TRIAZOLO[1,5-A]PYRIDINE | 2013 |
|
RU2563254C2 |
| NEW COMPOUND OF BENZIMIDAZOLONE AND ITS PHARMACEUTICAL USE | 2018 |
|
RU2803938C2 |
| NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND USE THEREOF IN INCREASING ENDOGENOUS ERYTHROPOIETIN | 2004 |
|
RU2379291C2 |
